相似文献
1
Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.
Proc Natl Acad Sci U S A. 1979 Dec;76(12):6557-61. doi: 10.1073/pnas.76.12.6557.
2
Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.
Infect Immun. 1982 Feb;35(2):417-24. doi: 10.1128/iai.35.2.417-424.1982.
3
Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
Infect Immun. 1980 Mar;27(3):826-31. doi: 10.1128/iai.27.3.826-831.1980.
4
Macrophage stimulation in vitro by an inactive muramyl dipeptide derivative after conjugation to a multi-poly(DL-alanyl)-poly(L-lysine) carrier.
Infect Immun. 1980 Apr;28(1):1-5. doi: 10.1128/iai.28.1.1-5.1980.
5
Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.
Proc Natl Acad Sci U S A. 1978 Jul;75(7):3395-9. doi: 10.1073/pnas.75.7.3395.
6
Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Z Immunitatsforsch Immunobiol. 1978 Oct;155(1):87-92.
7
Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs.
Infect Immun. 1979 Apr;24(1):83-9. doi: 10.1128/iai.24.1.83-89.1979.
8
Stimulation of nonspecific host resistance to infection induced by muramyldipeptides.
Microbiol Immunol. 1981;25(10):1047-58. doi: 10.1111/j.1348-0421.1981.tb00111.x.
9
Fate of two 14C labelled muramyl peptides: Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm and Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm-D-Ala-D-Ala in mice. Evaluation of their ability to increase non specific resistance to Klebsiella infection.
Int J Immunopharmacol. 1982;4(3):143-9. doi: 10.1016/0192-0561(82)90042-x.
10
Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections.
Infect Immun. 1982 Jul;37(1):292-300. doi: 10.1128/iai.37.1.292-300.1982.
引用本文的文献
1
Peptides and proteins as drugs.
Pharm Res. 1985 Jul;2(4):151-6. doi: 10.1023/A:1016327803573.
2
Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.
J Clin Invest. 2008 Feb;118(2):545-59. doi: 10.1172/JCI33145.
3
Pericholangitis in a rabbit colitis model induced by injection of muramyl dipeptide emulsified with a long-chain fatty acid.
J Gastroenterol. 1996 Jun;31(3):347-52. doi: 10.1007/BF02355023.
4
Extraintestinal manifestations of granulomatous enterocolitis induced in rabbits by long-term submucosal administration of muramyl dipeptide emulsified with Freund's incomplete adjuvant.
J Gastroenterol. 1996 Apr;31(2):199-206. doi: 10.1007/BF02389518.
5
Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice.
Infect Immun. 1980 Nov;30(2):462-6. doi: 10.1128/iai.30.2.462-466.1980.
6
Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
Infect Immun. 1980 Mar;27(3):826-31. doi: 10.1128/iai.27.3.826-831.1980.
7
Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.
Infect Immun. 1981 Dec;34(3):676-83. doi: 10.1128/iai.34.3.676-683.1981.
8
Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice.
Infect Immun. 1981 Feb;31(2):716-22. doi: 10.1128/iai.31.2.716-722.1981.
9
Muramyl peptides. Chemical structure, biological activity and mechanism of action.
Mol Cell Biochem. 1981 Dec 4;41:27-47. doi: 10.1007/BF00225295.
10
Successful immunization with a totally synthetic diphtheria vaccine.
Proc Natl Acad Sci U S A. 1982 Aug;79(16):5042-6. doi: 10.1073/pnas.79.16.5042.
本文引用的文献
1
Studies on the types of immune responses to synthetic antigens in guinea-pigs.
Immunology. 1966 Dec;11(6):561-70.
2
Role of optical configuration in the immunogenicity and specificity of synthetic antigens derived from multichain polyproline.
J Biol Chem. 1968 Nov 10;243(21):5616-26.
3
Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.
Biochem Biophys Res Commun. 1974 Aug 19;59(4):1317-25. doi: 10.1016/0006-291x(74)90458-6.
4
Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.
Biken J. 1975 Jun;18(2):105-11.
5
[Protective effects of bacterial immunostimulants in mice infected by "Klebsiella pneumoniae" resistant to antibiotics after mutation or by plasmid transfer].
Ann Immunol (Paris). 1975 Apr;126(3):319-26.
6
Modulation of the immune response by a synthetic adjuvant and analogs.
Proc Natl Acad Sci U S A. 1976 Jul;73(7):2472-5. doi: 10.1073/pnas.73.7.2472.
7
Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse.
Int J Immunopharmacol. 1979;1(1):35-41. doi: 10.1016/0192-0561(79)90028-6.
8
Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.
Prog Allergy. 1978;25:63-105.
9
Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.
Proc Natl Acad Sci U S A. 1978 Jul;75(7):3395-9. doi: 10.1073/pnas.75.7.3395.
10
Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.
Proc Natl Acad Sci U S A. 1977 May;74(5):2089-93. doi: 10.1073/pnas.74.5.2089.
Zotero 插件